RUNX1 and acute myeloid leukemia: The 30 molecules were initially screened in a cell viability assay after a 96 h treatment utilizing the CellTiter-Glo® assay in the AML cell line SKNO-1 carrying the t(8;21) translocation that results in RUNX1/ETO.